Microbial epidemiology and carriage studies for the evaluation of vaccines

Abigail L. Coughtrie(University of Southampton), Stuart C. Clarke(University Hospital Southampton NHS Foundation Trust), David Cleary(University of Birmingham), Johanna M. Jefferies(University Hospital Southampton NHS Foundation Trust), Mark Mullee(University of Southampton), C. Patrick Doncaster(University of Southampton), Jeremy S. Webb(University of Southampton), Michael Moore(Indiana University School of Medicine), Saul N. Faust(University Hospital Southampton NHS Foundation Trust), Ho Ming Yuen(University of Southampton), Alex R. Kraaijeveld(University of Southampton), Paul Roderick
Journal of Medical Microbiology
August 16, 2019
10.1099/jmm.0.001046
Cited by 7

Related Papers

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
|The Lancet|2020|5k
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
|The Lancet|2021|1.2k
Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children
|Pediatric Critical Care Medicine|2020|1.2k
A characterization of DNA release in <i>Pseudomonas aeruginosa</i> cultures and biofilms
|Molecular Microbiology|2005|1.1k